YK6-18791-16707
3 vaccinations
6 coded responses
27 check-ins
6 free-text entries
5 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 920 / CA
- Registered
- 2021-01-15
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-22
Dose 1 — Moderna
-
2021-01-15
Registered in v-safe
-
2021-01-15
Dose 2 — Moderna
- 2021-01-15
- 2021-01-15
-
2021-01-16
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-16
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
-
2021-01-17
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-17
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
- 2021-01-18
- 2021-01-19
- 2021-01-21
- 2021-01-24
- 2021-01-31
-
2021-02-05
Survey response — day 21, dose 2MedDRA: Headache — Feeling: Good · Be unable to workFree text: Persistent headacheMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-12
Survey response — day 28, dose 2MedDRA: Headache, Nausea — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Headache, nauseaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-12
Report sent to call center — day 28, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-02-19
Survey response — day 35, dose 2MedDRA: Dizziness, Headache, Nausea — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Dizziness, nausea, headacheMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-19
Report sent to call center — day 35, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-02-26
- 2021-04-16
- 2021-07-28
- 2021-07-28
-
2021-10-30
Dose 3 — Moderna
- 2021-10-30
-
2021-10-31
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-11-01
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-11-02
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Headache, Fatigue or tiredness, Nausea · Be unable to work or attend schoolAdult check-in
-
2021-11-03
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-11-04
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Headache, Fatigue or tiredness · Be unable to work or attend schoolAdult check-in
-
2021-11-05
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
- 2021-11-06
- 2021-11-13
- 2021-11-22
-
2021-11-29
Survey response — day 28, dose 3MedDRA: Migraine — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Worsening migraineMedDRA releases: 2024-11 · check-in free text available
-
2022-01-31
Survey response — 3 months, dose 3MedDRA: Headache, Throat irritation, Upper-airway cough syndrome — Feeling: Fair · Be unable to work or attend schoolFree text: Scratchy throat, post-nasal drip, headacheMedDRA releases: 2024-11 · check-in free text available
-
2022-10-30
Survey response — 12 months, dose 3MedDRA: COVID-19, Pregnancy — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: I currently have covid. Also Im pregnant.MedDRA releases: 2024-11 · check-in free text available
-
2022-10-30
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-10-31
Call successfulNot applicable - Accidental Reporting
-
2022-10-31
Call successfulNot applicable - Accidental Reporting
-
2022-10-31
Call successfulNot applicable - Accidental Reporting
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-22 | Moderna | |
| 2 | 2021-01-15 | Moderna | |
| 3 | 2021-10-30 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-16 | priority 2/3 | |
| 2021-01-17 | priority 2/3 | |
| 2021-02-12 | Successful 2022-10-31 |
Not applicable - Accidental Reporting |
| 2021-02-19 | Successful 2022-10-31 |
Not applicable - Accidental Reporting |
| 2022-10-30 | Successful 2022-10-31 |
Not applicable - Accidental Reporting |
Free text
Release 3 — day 21, dose 2
Symptoms: Persistent headache
Release 4 — day 28, dose 2
Symptoms: Headache, nausea
Release 4 — day 35, dose 2
Symptoms: Dizziness, nausea, headache
Release 10 — day 28, dose 3
Symptoms: Worsening migraine
Release 11 — 3 months, dose 3
Symptoms: Scratchy throat, post-nasal drip, headache
Release 12 — 12 months, dose 3
Symptoms: I currently have covid. Also Im pregnant.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Dizziness | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Migraine | · | · | ✓ |
| SD | Nausea | ✓ | ✓ | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SD | Throat irritation | · | · | ✓ |
| SD | Upper-airway cough syndrome | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release